Gene: GFPT1
Official Full Name: glutamine--fructose-6-phosphate transaminase 1provided by HGNC
Gene Summary: This gene encodes the first and rate-limiting enzyme of the hexosamine pathway and controls the flux of glucose into the hexosamine pathway. The product of this gene catalyzes the formation of glucosamine 6-phosphate. [provided by RefSeq, Sep 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37676 | GFPT1 Knockout cell line (HeLa) | Human | GFPT1 | 1:3~1:6 | Negative | Online Inquiry |
KO37677 | GFPT1 Knockout cell line (HCT 116) | Human | GFPT1 | 1:2~1:4 | Negative | Online Inquiry |
KO37678 | GFPT1 Knockout cell line (HEK293) | Human | GFPT1 | 1:3~1:6 | Negative | Online Inquiry |
KO37679 | GFPT1 Knockout cell line (A549) | Human | GFPT1 | 1:3~1:4 | Negative | Online Inquiry |
GFPT1 Gene Knockout Cell Lines are specially engineered cell lines designed for the targeted deletion of the GFPT1 gene, which encodes the enzyme glutamine-fructose-6-phosphate transaminase 1. This gene plays a critical role in the hexosamine biosynthetic pathway (HBP), a metabolic pathway implicated in various cellular processes, including glycosylation, stress response, and insulin signaling. By utilizing CRISPR-Cas9 technology for effective gene editing, these knockout cell lines allow researchers to investigate the biological functions and therapeutic implications of GFPT1 in a controlled environment.
The key mechanism by which GFPT1 Gene Knockout Cell Lines operate involves the selective disruption of the GFPT1 gene, leading to the absence of its associated enzyme. This knockout effect facilitates in-depth studies into cellular metabolism and its effects on cellular phenotypes, paving the way for exploration into conditions such as obesity, diabetes, and cancer where the HBP has been found to be dysregulated. By providing a robust model to elucidate the signaling pathways pertinent to GFPT1, researchers can better understand disease mechanisms and identify novel therapeutic targets.
The scientific importance of these cell lines cannot be overstated, as they serve as critical tools in basic and applied research settings. Their applications range from drug development and testing to elucidating metabolic disorders and understanding cancer cell metabolism. Compared to traditional knockout methodologies, GFPT1 Gene Knockout Cell Lines represent a more precise and efficient approach, minimizing off-target effects and improving the reproducibility of results.
One distinct advantage of our GFPT1 Gene Knockout Cell Lines lies in their ready-to-use nature, offering researchers a streamlined process to obtain reliable data without the extensive time commitment often required for creating custom knockout lines. Additionally, they are backed by extensive characterization data, ensuring their utility across various research applications.
We understand the intrinsic challenges researchers face in elucidating complex biological pathways, and we remain committed to providing high-quality gene editing tools that empower scientific inquiry. Our expertise in molecular biology and commitment to innovation positions us uniquely to support advancements in life sciences. Choose our GFPT1 Gene Knockout Cell Lines for a dependable, cutting-edge solution to drive your research forward.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.